Veröffentlichungen | MDC Berlin

18 Ergebnisse:

Active Filter:

02. Dezember 2010 in PLoS Genet

Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells

K. Juerchott
R.J. Kuban
T. Krech
N. Blüthgen
U. Stein
W. Walther
C. Friese
S.M. Kielbasa
U. Ungethuem
P. Lund
T. Knoesel
W. Kemmner
M. Morkel
J. Fritzmann
P.M. Schlag
W. Birchmeier
T. Krueger
S. Sperling
C. Sers
H.D. Royer
H. Herzel
R. Schaefer

01. Mai 2010 in Nat Med

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

B. Lamprecht
K. Walter
S. Kreher
R. Kumar
M. Hummel
D. Lenze
K. Koechert
M.A. Bouhlel
J. Richter
E. Soler
R. Stadhouders
K. Joehrens
K.D. Wurster
D.F. Callen
M.F. Harte
M. Giefing
R. Barlow
H. Stein
I. Anagnostopoulos
M. Janz
P.N. Cockerill
R. Siebert
B. Doerken
C. Bonifer
S. Mathas

15. April 2010 in Clin Cancer Res

T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy

M. Leisegang
A. Turqueti-Neves
B. Engels
T. Blankenstein
D.J. Schendel
W. Uckert
E. Noessner

01. November 2006 in Eur J Immunol

Designer T cells by T cell receptor replacement

D. Sommermeyer
J. Neudorfer
M. Weinhold
M. Leisegang
B. Engels
E. Noessner
M.H. Heemskerk
J. Charo
D.J. Schendel
T. Blankenstein
H. Bernhard
W. Uckert

15. Mai 2006 in Cell Cycle

Reprogramming of B lymphoid cells in human lymphoma pathogenesis

M. Janz
B. Doerken
S. Mathas

10. Mai 2006 in BMC Cancer

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy

I. Sturm
B. Rau
P.M. Schlag
P. Wust
B. Hildebrandt
H. Riess
S. Hauptmann
B. Doerken
P.T. Daniel

01. April 2006 in Cell Death Differ

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma

I. Sturm
C. Stephan
B. Gillissen
R. Siebert
M. Janz
S. Radetzki
K. Jung
S. Loening
B. Doerken
P.T. Daniel

15. März 2006 in Blood

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells

M. Janz
M. Hummel
M. Truss
B. Wollert-Wulf
S. Mathas
K. Joehrens
C. Hagemeier
K. Bommert
H. Stein
B. Doerken
R.C. Bargou

01. Februar 2006 in Nat Immunol

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

S. Mathas
M. Janz
F. Hummel
M. Hummel
B. Wollert-Wulf
S. Lusatis
I. Anagnostopoulos
A. Lietz
M. Sigvardsson
F. Jundt
K. Joehrens
K. Bommert
H. Stein
B. Doerken

01. Januar 2006 in Int J Cancer

Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases

O.R. Bandapalli
M. Geheeb
D. Kobelt
K. Kuehnle
S. Elezkurtaj
J. Herrmann
A.M. Gressner
R. Weiskirchen
D. Beule
N. Blüthgen
H. Herzel
C. Franke
K. Brand